Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. 

Biotechnology

Atomwise

Gavin Hirst

Wenhu Huang

Matthew Merkley

Mallorie Lynch

Ed Kawashiri

Robert Mittendorff

Izhar Wallach

Denzil Bernard

Yan Zhao

Nicole Dishotsky

The Scientific Research Team at Atomwise leverages advanced deep learning and cheminformatics to drive innovative drug discovery. This group collaborates to analyze vast datasets of protein structures and molecular interactions, developing algorithms and models that expedite the identification and optimization of potential small molecule therapeutics.

Scientific Research Team

Drug Discovery and Medicinal Chemistry

Leadership Team

Directors Team

Scientific Research Team

About

Team members

Other teams at Atomwise

Drug Discovery and Medicinal Chemistry

Leadership Team

Directors Team